Private Portfolio Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2.46M Buy
3,189
+459
+17% +$380K 0.45% 42
2024
Q3
$2.42M Buy
+2,730
New +$2.45M 0.45% 43
2024
Q2
Sell
-2,606
Closed -$2.03M 182
2024
Q1
$2.03M Sell
2,606
-61
-2% -$43.4K 0.42% 48
2023
Q4
$1.55M Buy
2,667
+48
+2% +$28K 0.36% 53
2023
Q3
$1.41M Buy
2,619
+184
+8% +$94.8K 0.36% 57
2023
Q2
$1.14M Buy
2,435
+130
+6% +$54.5K 0.29% 66
2023
Q1
$792K Buy
2,305
+129
+6% +$43.5K 0.21% 84
2022
Q4
$796K Sell
2,176
-174
-7% -$61.7K 0.21% 91
2022
Q3
$760K Sell
2,350
-25
-1% -$7.92K 0.22% 92
2022
Q2
$770K Buy
2,375
+1
+0% +$300 0.21% 93
2022
Q1
$680K Buy
2,374
+1,396
+143% +$359K 0.17% 120
2021
Q4
$270K Buy
+978
New +$248K 0.07% 230

Other funds holding LLY

Private Portfolio Partners's LLY Position: Q4 2024 in Review

Private Portfolio Partners increased its Eli Lilly (LLY) stake by 17% in Q4 2024, buying an estimated $380K and bringing the position to 3,189 shares worth $2.46M. The position accounts for 0.45% of the portfolio, ranked #42.

Private Portfolio Partners first reported a position in LLY in Q4 2021 and has held it in 12 quarters since. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Private Portfolio Partners held 3,189 shares of Eli Lilly worth $2.46M as of Q4 2024.
  • Private Portfolio Partners bought 459 Eli Lilly shares in Q4 2024, an estimated $380K.
  • Eli Lilly made up 0.45% of Private Portfolio Partners's portfolio in Q4 2024, its #42 holding.
  • Private Portfolio Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 12 quarters since.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Private Portfolio Partners's 13F filing for Q4 2024, filed 12 Feb 2025.